News
Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback